Camp4 Therapeutics Corporation (CAMP)

NASDAQ: CAMP · Real-Time Price · USD

4.210

+0.760 (22.03%)

At close: Aug 3, 2026, 4:00 PM EDT

4.250

+0.040 (0.95%)

After-hours: Aug 3, 2026, 7:54 PM EDT

Camp4 Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Net Income	-86.3	-80.4	-51.79	-49.29	-44.19
Depreciation & Amortization	1.74	1.64	1.7	1.68	0.88
Stock-Based Compensation	4.61	4	4.03	2.91	1.38
Other Adjustments	1.39	32.21	1.83	1.82	1.69
Changes in Accounts Payable	-0.61	-1.03	0.17	-1.12	1.33
Changes in Accrued Expenses	2.22	0.81	1.53	-0.14	1.89
Changes in Unearned Revenue	16.29	17.12	0.39	-	-
Changes in Other Operating Activities	-2.04	-3.88	-3.42	-0.02	-1.52
Operating Cash Flow	-26.25	-29.55	-45.56	-44.16	-38.54
Operating Cash Flow Growth	-	-	-	-	-
Capital Expenditures	-	-0.28	-0.44	-0.68	-4.03
Sale of Property, Plant & Equipment	-	0.04	-	-	-
Investing Cash Flow	0.04	-0.24	-0.44	-0.68	-4.03
Long-Term Debt Issued	-	-	-	0.71	-
Long-Term Debt Repaid	0.02	-0.1	-0.46	-0.27	-
Net Long-Term Debt Issued (Repaid)	0.02	-0.1	-0.46	0.44	-
Issuance of Common Stock	32.62	61.17	76.47	0.19	0.06
Net Common Stock Issued (Repurchased)	32.62	61.17	76.47	0.19	0.06
Issuance of Preferred Stock	-	-	-	-	100.2
Net Preferred Stock Issued (Repurchased)	-	-	-	-	100.2
Other Financing Activities	-0.08	14.82	-4.34	-0.32	-0.09
Financing Cash Flow	76.1	75.89	71.66	0.3	100.16
Net Cash Flow	49.89	46.09	25.66	-44.53	57.59
Free Cash Flow	-26.25	-29.83	-46	-44.83	-42.57
Free Cash Flow Growth	-	-	-	-	-
FCF Margin	-667.21%	-852.83%	-7055.67%	-12809.40%	-
Free Cash Flow Per Share	-0.66	-0.98	-9.81	-113.51	-119.32
Levered Free Cash Flow	-0.71	-66.13	-52.33	-49.12	-45.64
Unlevered Free Cash Flow	-34.92	-38.19	-53.16	-52.15	-46.44

SEC Filings: 10-K · 10-Q